| 764378 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
597 The role of CCL20 in mediating regulatory T cell infiltration and resistance to radiotherapy in head and neck squamous cell carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.597 |
Rutihinda Cleopatra, Moreau Leanié, Chelighem Safia, Oweida Ayman |
| 764377 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
596 Combining Bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) pairs local innate activation with systemic CD8+ T cell expansion to enhance anti-tumor immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.596 |
Rolig Annah, Rose Daniel, McGee Grace Helen, Kivimae Saul, Rubas Werner, Redmond William |
| 764376 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
595 Inhibition of integrin αvβ8 in combination with low dose radiation induces antitumor effect in advanced immune checkpoint blockade refractory tumor model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.595 |
Reszka-Blanco Natalia, Krumpoch Megan, Mentzer Michaela, Yadav Vinod Yadav, Bannister Brianna, Cui Dan, Konopka Elizabeth, Lee Dooyoung, Lin Fu-Yang, Moy Terence, Nebelitsky Eugene, Qiao Qi, Smutske Inese, Root Charlotte, Allison Patrick, Krueger Sarah, Troast Dawn, Lippa Blaise, Rogers Bruce, Ray Adrian |
| 764375 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
594 Combination of antigen-specific vaccination and targeted radionuclide therapy improves anti-tumor efficacy in a murine prostate model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.594 |
Potluri Hemanth, Ferreira Carolina, Grudzinski Joseph, Massey Christopher, Hernandez Reinier, Weichert Jamey, McNeel Douglas |
| 764374 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
269 Utilizing serum proteome to understand response and resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.269 |
Kim Leeseul, Chae Young Kwang, Lee Dong-Uk |
| 764373 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
266 AK117, a CD47 blocking antibody with robust macrophage activation without red blood cell hemagglutination |
2021-11-01 |
10.1136/jitc-2021-sitc2021.266 |
Huang Zhaoliang, Pang Xinghua, Zhong Tingting, Qu Tailong, Jin Chunshan, Chen NA, He Xinrong, Xia Dennis, Jin Xiaoping, Wang Zhongmin, Xia Xu, Li Baiyong |
| 764372 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
265 CD47xPD-L1 bispecific antibodies for cancer therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.265 |
Chauchet Xavier, Pernarrieta Elise, Bosson Nicolas, Calloud Sébastien, Hellequin Louis, Legrand Margaux, Viandier Alizée, Richard Françoise, Cons Laura, Malinge Pauline, Bautzova Tereza, Bourguignon Jérémie, Pontini Guillemette, Sun Mengzhu, Ravn Ulla, Moine Valéry, Poitevin Yves, Hugues Stéphanie, Fischer Nicolas, Shang Limin, Ferlin Walter, Masternak Krzysztof |
| 764371 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
261 A functional genetic screen uncovers regulators of intratumoral macrophage function and reveals CD24 as a novel target for cancer immunotherapy by macrophages |
2021-11-01 |
10.1136/jitc-2021-sitc2021.261 |
Barkal Amira, Brewer Rachel, Weissman Irving |
| 764370 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
257 Combination of adenosine antagonists A2AR (TT-10) and A2BR (TT-4) with checkpoint inhibitors demonstrate anti-tumor activity in CT-26 murine colon tumor allograft model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.257 |
Pastore Desa Rae, Kumar Sushant, Schwartz Brian, Mookhtiar Kasim, Reddy Vijay |
| 764369 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
252 Novel DNAM-1 axis member, PVRIG, is potentially a dominant checkpoint involved in stem-like memory T cells – dendritic cell interaction |
2021-11-01 |
10.1136/jitc-2021-sitc2021.252 |
Alteber Zoya, Cojocaru Gady, Frenkel Masha, Weyl Emmanuel, Sabath Niv, Wool Assaf, Novik Amit, Kliger Yossef, Levine Zurit, Ophir Eran |
